Cobram Estate Olives Ltd (CBO)
Australian Securities Exchange · Australia · prices in AUD · close of 19 Oct 2026
Key indicators
| Last close | AUD 2.750 |
|---|---|
| 52-week range | 2.479 – 4.367 |
| Return, 1 month / 3 months | −6.5% / −15.5% |
| Return, 1 year / 3 years | −20.3% / +122.2% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 44.9% |
| Worst drawdown (1 year) | -38.3% |
| Average daily value traded | 3.89M AUD |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cobram Estate Olives is an Australian olive oil company that grows olives and produces extra virgin olive oil. Its products are sold under the Cobram Estate and Red Island brands to grocery retailers and food service customers in Australia and overseas. The company is based in Victoria and also operates olive groves and processing facilities in California, giving it a presence in both the Australian and American olive oil markets.
The shares are listed on the Australian Securities Exchange in Australia under the code CBO, and the price on this page is in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cobram Estate Olives Ltd (CBO) trades on the Australian Securities Exchange in Australia. It last closed at AUD 2.750 on 19 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 677 of 1,815 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.3% and over the last three months it fell 15.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -18.9% | ||
| From 52-week high | -36.5% | ||
| Momentum | 42 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -15.5% | ||
| 6-month return | -21.5% | ||
| 12-month return, skipping the last month | -14.8% | ||
| Stability (higher is calmer) | 74 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.3% | ||
| Liquidity | 86 · Strong | Trades actively. | |
| Average daily value traded | 3.89M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | 60 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −4.9% |
|---|---|
| 1 month | −6.5% |
| 3 months | −15.5% |
| 6 months | −21.5% |
| 1 year | −20.3% |
| 3 years | +122.2% |
| 5 years | +51.1% |
Signals
| 50-day / 200-day average | 2.955 / 3.391 |
|---|---|
| Golden / death cross (60 days) | Death, 33 days ago |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.126 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Oct 2026 | AUD 0.0450 |
| 6 Nov 2025 | AUD 0.0450 |
| 7 Nov 2024 | AUD 0.0330 |
| 23 Nov 2023 | AUD 0.0330 |
| 17 Nov 2022 | AUD 0.0330 |
| 18 Nov 2021 | AUD 0.0330 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.